Incyte (INCY) Change in Inventory (2012 - 2026)
Incyte's (INCY) quarterly Change in Inventory came in at $11.9 million in Q2 2026, down 39.16% YoY from $19.5 million in Q2 2025, and down 2.84% on a QoQ basis from $12.2 million in Q1 2026.
Incyte (INCY) Change in Inventory (2012 - 2026) Analysis & Trends
Incyte (INCY) has 15 years of Change in Inventory data on file, last reported at $11.9 million in Q2 2026.
- Quarterly Change in Inventory fell 39.16% year-over-year to $11.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $34.5 million (down 61.97% YoY) and the FY2025 annual result came in at $58.5 million, down 54.16% from the prior year.
- Change in Inventory declined to $11.9 million in Q2 2026, from $12.2 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $93.0 million in Q4 2023 to a low of $4.9 million in Q4 2025.
- A 5-year average of $24.9 million and a median of $19.8 million in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory surged 15552.78% — and 2025, when it slumped 85.83%.
- Tracing INCY's Change in Inventory over 5 years: stood at $19.2 million in 2022, then soared by 384.46% to $93.0 million in 2023, then sank by 63.12% to $34.3 million in 2024, then tumbled by 85.83% to $4.9 million in 2025, then soared by 144.47% to $11.9 million in 2026.
- The last three Change in Inventory figures came in at $11.9 million (Q2 2026), $12.2 million (Q1 2026), and $4.9 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Incyte | 24.15 Bn | 19.61 Bn | 1.57 Bn | 11.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.88 Mn |
| Jun 30, 2026 | 11.88 Mn |
| Mar 31, 2026 | 12.23 Mn |
| Mar 31, 2026 | 12.23 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Sep 30, 2025 | 5.56 Mn |
| Sep 30, 2025 | 5.56 Mn |
| Jun 30, 2025 | 19.53 Mn |
| Jun 30, 2025 | 19.53 Mn |
| Mar 31, 2025 | 28.57 Mn |
| Mar 31, 2025 | 28.57 Mn |
| Dec 31, 2024 | 34.28 Mn |
| Dec 31, 2024 | 34.28 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 27.78 Mn |
| Jun 30, 2024 | 27.78 Mn |
| Mar 31, 2024 | 57.20 Mn |
| Mar 31, 2024 | 57.20 Mn |